Biotech14 hours ago
Novo Nordisk: Ozempic Gets Positive Evaluation for Kidney Treatment
Ozempic, manufactured by Novo Nordisk, gains EMA approval for chronic kidney disease, reducing disease progression by 24%, per the Flow trial. With 40% of type 2...